Insiders / Papadopoulos Stelios
Papadopoulos Stelios
CIK 1202098personinsider
Companies
2
First seen
Mar 2, 2026
Last activity
May 29, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Exelixis, Inc. · EXEL | 1,197,595 | — |
| Ovid Therapeutics Inc. · OVID | 217,578 | — |
All securities held
3 positions · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| Exelixis, Inc. | Common Stock | 1,197,595 |
| Ovid Therapeutics Inc. | Common Stock | 217,578 |
| Ovid Therapeutics Inc. | Employee Stock Option (Right to Buy)Derivative | 65,000 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Apr 7, 2026 | Grant | OVID Ovid Therapeutics Inc. Common Stock | $45.0K | +18K +8.79% | 217,578 0.11% of shares | low |
| May 27, 2026 | Grant | EXEL Exelixis, Inc. Common Stock | $0 | +8K +0.70% | 1,197,595 0.48% of shares | low |
| Feb 26, 2026 | Grant | OVID Ovid Therapeutics Inc. Employee Stock Option (Right to Buy) | — | +65K | 65,000 0.03% of shares | low |